RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $903,000 | -64.1% | 18,816 | -64.8% | 0.02% | +53.3% |
| Q4 2019 | $2,512,000 | +170.4% | 53,530 | +73.3% | 0.02% | +66.7% |
| Q2 2019 | $929,000 | +34.1% | 30,880 | -0.2% | 0.01% | +28.6% |
| Q1 2019 | $693,000 | +1.3% | 30,943 | -17.7% | 0.01% | -12.5% |
| Q4 2018 | $684,000 | -28.9% | 37,602 | -29.3% | 0.01% | -33.3% |
| Q3 2018 | $962,000 | +524.7% | 53,199 | +242.8% | 0.01% | +500.0% |
| Q2 2018 | $154,000 | -7.8% | 15,521 | -20.8% | 0.00% | -33.3% |
| Q4 2017 | $167,000 | -15.2% | 19,592 | +86.6% | 0.00% | -25.0% |
| Q2 2017 | $197,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $288,094,000 | 13.62% |
| RA Capital Management | 4,858,260 | $227,998,000 | 6.91% |
| HAVENS ADVISORS LLC | 116,000 | $5,444,000 | 4.77% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,115,600 | $99,286,000 | 3.16% |
| SYQUANT CAPITAL SAS | 129,690 | $6,086,000 | 3.13% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 391,758 | $18,386,000 | 3.02% |
| Kellner Capital, LLC | 91,100 | $4,275,000 | 2.71% |
| Telemetry Investments, L.L.C. | 17,100 | $803,000 | 2.68% |
| Versor Investments LP | 1,002,649 | $47,054,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,519,718 | $71,320,000 | 2.28% |